ArticleNature reviews. Urology2024
Pembrolizumab plus enfortumab vedotin in urothelial cancer.
Matteo Santoni et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleNature reviews. Urology2024
Matteo Santoni et al.PubMed ↗Publisher ↗
No numbers read from the abstract.